⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Millicent Pharma and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Millicent Pharma
↗Dundalk, Ireland
Millicent Pharma is a specialty pharmaceutical company dedicated to advancing women's health through the development, acquisition, and commercialization of innovative therapies. The company focuses on areas including contraception, menopause, and fertility, aiming to provide patient-focused solutions across a woman's life journey.
Founded in 2018 in collaboration with The Carlyle Group and veteran pharmaceutical leaders, the company has established international operations with headquarters in Dundalk, Ireland, and significant manufacturing and R&D activities in Northern Ireland and Puerto Rico. Millicent actively pursues a growth strategy through both internal R&D and strategic in-licensing and acquisitions.
CLASSIFICATION
SIZE & FINANCIALS
Employees:51-200
Founded:2018
Ownership:private
Status:operating
FUNDING
Stage:Private
Investors:The Carlyle Group
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Small molecule
Trial Phases:-
FDA Approvals:3
CORPORATE STRUCTURE
Subsidiaries:Millicent Manufacturing PR, LLC, Millicent US, Inc.
Key Partnerships:Prasco (Ordering/Distribution)
COMPETITION
Position:Niche Player
LEADERSHIP
Key Executives:
Andy McClenaghan - CEO
Frank McGeath - CFO
Ryan Loughlin - SVP, Head of Technical Operations and Quality
LINKS
Website:millicentpharma.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Millicent Pharma. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.